Healthcare - Biotechnology - NASDAQ - US
$ 6.56
39.6 %
$ 24 M
Market Cap
-2.2
P/E
CASH FLOW STATEMENT
-16 M
OPERATING CASH FLOW
-676 K
INVESTING CASH FLOW
53 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Pulmatrix, Inc.
| Net Income | -14.1 M |
| Depreciation & Amortization | 1.48 M |
| Capital Expenditures | -676 K |
| Stock-Based Compensation | 954 K |
| Change in Working Capital | -4.3 M |
| Others | -5.39 M |
| Free Cash Flow | -16.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Mar-2015 | Mar-2013 | Mar-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (14.1) | (18.8) | (20.2) | (19.3) | (20.6) | (20.6) | (18.1) | (27.8) | (26.2) | (3.1) | (0.5) | 30 K |
| Depreciation & Amortization | 1.5 | 1.5 | 1.2 | 1.0 | 0.8 | 0.2 | 0.2 | 0.2 | 0.2 | 2 K | 0.4 | 0 |
| Deferred Income Tax | 0 | (4.9) | 0 | 0 | 0 | 76 K | 34 K | 9.7 | 1.2 | 0 | 0 | 0 |
| Stock Based Compensation | 1.0 | 1.1 | 1.2 | 1.2 | 2.1 | 3.0 | 2.8 | 4.0 | 9.8 | 1.1 | 0.4 | 0 |
| Other Operating Activities | 8 K | 4.9 | 3.6 | 9.3 | 7.3 | 38 K | 0.2 | 0.3 | 1.6 | 14.9 | 2.4 | 0 |
| Change in Working Capital | (4.3) | (3.2) | (5.5) | (4.7) | 13.7 | 0.5 | 0.3 | 0.4 | 0.9 | 0.1 | 97 K | 0 |
| Cash From Operations | (16.0) | (19.4) | (19.7) | (12.5) | 3.2 | (16.8) | (14.5) | (13.2) | (12.5) | (3.0) | (0.4) | 30 K |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.7) | 86 K | (0.1) | (0.3) | 58 K | 19 K | 74 K | (0.5) | (0.3) | (0.2) | 4 K | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 K | 9.7 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.7) | 86 K | (0.1) | (0.3) | 58 K | 19 K | 74 K | (0.4) | 9.4 | (0.2) | 4 K | 0 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | (3.5) | (2.7) | (1.0) | 11.4 | 0 | 1.7 | 0.6 |
| Dividends Paid | 0 | 0 | (3.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (0.2) | 9.6 | 13.7 | 0.2 | 0 | 0.3 | 0 | 0.2 | 7.6 | (17.4) | 0 |
| Cash From Financing Activities | 53 K | 1.2 | 43.5 | 21.0 | 17.7 | 15.8 | 13.9 | (1.0) | 21.5 | 18.4 | 0.5 | 30 K |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (16.6) | (18.2) | 23.6 | 8.2 | 20.9 | (1.0) | (0.6) | (14.7) | 18.5 | 15.5 | 96 K | 0 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (16.7) | (19.4) | (19.9) | (12.8) | 3.2 | (16.8) | (14.6) | (13.7) | (12.7) | (3.1) | (0.4) | 30 K |